Synthetic pig cutaneous development substance (rEGF) is receiving increased interest as a promising strategy in the area of tissue medicine. This bioactive agent, produced through recombinant processes, provides a https://recombinantporcineegf386687.activosblog.com/41470859/synthetic-porcine-skin-growth-protein-a-effective-agent-for-wound-regeneration